February 2, 2017
(New Scientist) – A new vaccine against Zika virus gives mice and monkeys immunity in tests. The vaccine is based on the inactivated virus, and just one low dose is needed. “The critical difference between ours and everybody else’s is that it’s not a live virus. That makes it much safer and much easier to produce,” says Drew Weissman at the University of Pennsylvania, a member of the team that developed it.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.